Literature DB >> 21932058

Effects of combined levosimendan and vasopressin on pulmonary function in porcine septic shock.

Muhuo Ji1, Renqi Li, Guo-min Li, Yunxia Fan, Lin Dong, Jianjun Yang, Yong G Peng, Jing Wu.   

Abstract

This study aims to determine whether levosimendan combined with arginine vasopressin infusion supplemented with norepinephrine can improve hemodynamics and pulmonary dysfunction. The study was tested in a fecal peritonitis-induced septic shock model, we observed that levosimendan combined with arginine vasopressin supplemented with norepinephrine therapy resulted in lower mean pulmonary artery pressure, lactate concentrations, arterial total nitrate/nitrite, and high-mobility group box 1 levels; decreased lung wet/dry ratio, and pulmonary levels of interleukin-6, total histological scores, and improved pulmonary gas exchange when compared with norepinephrine group. Levosimendan combined with arginine vasopressin supplemented with norepinephrine infusion shows potential benefit in sepsis-induced acute lung injury by decreasing mean pulmonary artery pressure and attenuating inflammatory responses in the lung compared to norepinephrine infusion alone.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21932058     DOI: 10.1007/s10753-011-9388-3

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  32 in total

1.  Effects of levosimendan on circulating pro-inflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failure.

Authors:  John T Parissis; Stamatis Adamopoulos; Charalambos Antoniades; George Kostakis; Antonios Rigas; Stamos Kyrzopoulos; Efstathios Iliodromitis; Dimitrios Kremastinos
Journal:  Am J Cardiol       Date:  2004-05-15       Impact factor: 2.778

2.  Association of mitochondrial allele 4216C with increased risk for sepsis-related organ dysfunction and shock after burn injury.

Authors:  Ryan M Huebinger; Ruben Gomez; Daphne McGee; Ling-Yu Chang; Jessica E Bender; Terence O'Keeffe; Agnes M Burris; Susan M Friese; Gary F Purdue; John L Hunt; Brett D Arnoldo; Jureta W Horton; Robert C Barber
Journal:  Shock       Date:  2010-01       Impact factor: 3.454

3.  HMGB1 induces human lung endothelial cell cytoskeletal rearrangement and barrier disruption.

Authors:  Rachel K Wolfson; Eddie T Chiang; Joe G N Garcia
Journal:  Microvasc Res       Date:  2010-12-10       Impact factor: 3.514

4.  AVP inhibits LPS- and IL-1beta-stimulated NO and cGMP via V1 receptor in cultured rat mesangial cells.

Authors:  T Umino; E Kusano; S Muto; T Akimoto; S Yanagiba; S Ono; M Amemiya; Y Ando; S Homma; U Ikeda; K Shimada; Y Asano
Journal:  Am J Physiol       Date:  1999-03

5.  Decreased vasopressin responsiveness in vasodilatory septic shock-like conditions.

Authors:  Marc Leone; Walter A Boyle
Journal:  Crit Care Med       Date:  2006-04       Impact factor: 7.598

Review 6.  Acute lung injury review.

Authors:  Kenji Tsushima; Landon S King; Neil R Aggarwal; Antonio De Gorordo; Franco R D'Alessio; Keishi Kubo
Journal:  Intern Med       Date:  2009-05-01       Impact factor: 1.271

7.  Low-dose terlipressin improves systemic and splanchnic hemodynamics in fluid-challenged endotoxic rats.

Authors:  Pierre Asfar; Marc Pierrot; Nary Veal; Frédéric Moal; Frédéric Oberti; Vincent Croquet; Olivier Douay; Yves Gallois; Jean-Louis Saumet; Philippe Alquier; Paul Calès
Journal:  Crit Care Med       Date:  2003-01       Impact factor: 7.598

Review 8.  Extracellular role of HMGB1 in inflammation and sepsis.

Authors:  H Wang; H Yang; K J Tracey
Journal:  J Intern Med       Date:  2004-03       Impact factor: 8.989

9.  Efficacy and safety of dopamine versus norepinephrine in the management of septic shock.

Authors:  Gourang P Patel; Jaime Simon Grahe; Mathew Sperry; Sunit Singla; Ellen Elpern; Omar Lateef; Robert A Balk
Journal:  Shock       Date:  2010-04       Impact factor: 3.454

10.  Effects of levo- and dextrosimendan on NF-kappaB-mediated transcription, iNOS expression and NO production in response to inflammatory stimuli.

Authors:  O Sareila; R Korhonen; H Auvinen; M Hämäläinen; H Kankaanranta; E Nissinen; E Moilanen
Journal:  Br J Pharmacol       Date:  2008-08-18       Impact factor: 8.739

View more
  5 in total

1.  Protective Effects of Antioxidant Peptide SS-31 Against Multiple Organ Dysfunctions During Endotoxemia.

Authors:  Guoming Li; Jing Wu; Renqi Li; Dong Yuan; Yunxia Fan; Jianjun Yang; Muhuo Ji; Sihai Zhu
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

2.  Erythropoietin Pretreatment Attenuates Seawater Aspiration-Induced Acute Lung Injury in Rats.

Authors:  Mu-Huo Ji; Jian-Hua Tong; Yuan-Hui Tan; Zhen-Yu Cao; Cong-Yang Ou; Wei-Yan Li; Jian-Jun Yang; Y G Peng; Si-Hai Zhu
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

3.  Valproic acid attenuates lipopolysaccharide-induced acute lung injury in mice.

Authors:  Mu-huo Ji; Guo-min Li; Min Jia; Si-hai Zhu; Da-peng Gao; Yun-xia Fan; Jing Wu; Jian-jun Yang
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

Review 4.  Preclinical septic shock research: why we need an animal ICU.

Authors:  Antoine Guillon; Sebastien Preau; Jérôme Aboab; Eric Azabou; Boris Jung; Stein Silva; Julien Textoris; Fabrice Uhel; Dominique Vodovar; Lara Zafrani; Nicolas de Prost; Peter Radermacher
Journal:  Ann Intensive Care       Date:  2019-06-10       Impact factor: 6.925

5.  Levosimendan pretreatment improves survival of septic rats after partial hepatectomy and suppresses iNOS induction in cytokine-stimulated hepatocytes.

Authors:  Tatsuma Sakaguchi; Yuki Hashimoto; Hideyuki Matsushima; Hidehiko Hishikawa; Mikio Nishizawa; Tadayoshi Okumura; Masaki Kaibori
Journal:  Sci Rep       Date:  2019-09-16       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.